Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,426 | -28,349 | -17,775 | -9,231 | -32,543 |
| Depreciation Amortization | 210 | 156 | 103 | 51 | 194 |
| Income taxes - deferred | 576 | 432 | 288 | 144 | 576 |
| Accounts payable and accrued liabilities | 2,000 | -1,264 | -258 | -280 | 1,762 |
| Other Working Capital | -1,685 | -4,011 | -2,848 | -234 | -4,006 |
| Other Operating Activity | 10,124 | 10,747 | 6,569 | 3,415 | 4,957 |
| Operating Cash Flow | $-28,201 | $-22,289 | $-13,921 | $-6,135 | $-29,060 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -5,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-5,000 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,804 | 13,719 | N/A | 0 | 13,830 |
| Other Financing Activity | -3,831 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $9,972 | $13,719 | $0 | $0 | $13,830 |
| Beginning Cash Position | 26,481 | 26,481 | 26,481 | 26,481 | 41,712 |
| End Cash Position | 3,252 | 17,911 | 12,560 | 20,346 | 26,481 |
| Net Cash Flow | $-23,229 | $-8,570 | $-13,921 | $-6,135 | $-15,231 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,201 | -22,289 | -13,921 | -6,135 | -29,060 |
| Free Cash Flow | -28,201 | -22,289 | -13,921 | -6,135 | -29,060 |